Modified Amniotic Fluid Score With Fetal Bladder Assessment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Amniotic Fluid Scoring Model, Fetal Bladder Assessment. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Modified Amniotic Fluid Scoring Model Incorporating Fetal Bladder Assessment
Overview
This study will prospectively enroll pregnant women with singleton pregnancies between 20 and 38 weeks of gestation who attend Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid. The aim is to develop and validate a modified amniotic fluid scoring model that combines standard ultrasound measures of amniotic fluid volume with fetal bladder size and appearance. The study will compare the ability of this new scoring model to detect abnormal amniotic fluid volume against conventional ultrasound methods and will explore how fetal bladder measurements relate to amniotic fluid indices.
Detailed description
This prospective observational cohort study will be conducted in the Obstetrics and Gynecology Department at Assiut University Hospital and will enroll 70 pregnant women aged 18-45 years with singleton pregnancies between 20 and 38 weeks of gestation who are referred for routine or clinically indicated ultrasound assessment of amniotic fluid volume. The study aims to develop and validate a modified amniotic fluid scoring model that integrates standard sonographic measures of amniotic fluid volume, including the amniotic fluid index and single deepest pocket, with predefined fetal bladder parameters such as bladder presence, morphology, and longitudinal and transverse diameters measured at maximal filling.
Eligible participants will undergo a standardized ultrasound examination using a high-resolution machine with a curvilinear transducer; the uterus will be systematically scanned to obtain AFI and single deepest pocket measurements, followed by a dedicated five-minute assessment of the fetal bladder to document its size, appearance, and any observed micturition events. All sonographic assessments will be performed by experienced sonographers following uniform protocols, and approximately 10 percent of examinations will be re-scanned by a second sonographer to assess interobserver reliability, with images and measurements digitally archived for blinded review.
Primary outcome measures
- Sensitivity Of The Modified Amniotic Fluid Scoring Model [Time frame: At the index obstetric ultrasound examination during pregnancy (single visit per participant).]
Secondary outcome measures (1)
- Correlation Between Fetal Bladder Size And Amniotic Fluid Volume [Time frame: At the same index obstetric ultrasound examination during pregnancy (single visit per participant).]
Eligibility criteria
Inclusion criteria
- Pregnant women aged 18-45 years.
- Singleton pregnancy between 20 and 38 weeks of gestation.
- Women attending Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid volume.
- No known major fetal anomalies at the time of inclusion.
- Able and willing to provide written informed consent.
Exclusion criteria
- Multiple pregnancy (e.g., twins, triplets).
- Pregnancies with known chromosomal or major structural fetal anomalies diagnosed prior to enrollment.
- Maternal systemic diseases known to affect amniotic fluid volume (e.g., pregestational or gestational diabetes, chronic hypertension, renal disease).
- Contraindications to ultrasound examination.
- Inability to provide informed consent or anticipated poor compliance with study procedures.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07315243 · Modified Amniotic Fluid Score